GADETA
Gadeta is a research and development company that develops immunotherapies for cancer. It has developed a technology platform based on combinatorial T Cell receptor exchange (CTE) to create optimized gamma delta (γδ) T-cell receptors (TCRs) with enhanced anti-cancer reactivity. Gadeta’s new cell-based anti-cancer product called T Cells Engineered To Express A Defined Gamma Delta TCR (TEGs) has strong therapeutic potential for combating and eradicating both hematological and solid tumors. This approach utilizes high-affinity γδ TCRs expressed on αβ T cells with superior proliferation capacity.
GADETA
Industry:
Biotechnology Medical Therapeutics
Founded:
2015-01-01
Address:
Utrecht, Utrecht, The Netherlands
Country:
The Netherlands
Website Url:
http://www.gadeta.nl
Total Employee:
11+
Status:
Active
Contact:
+31 (0) 85 016 44 66
Total Funding:
7.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Apache Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail
Similar Organizations
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Advisors List
Advisor
Board_member
2002-01-01
Board_member
Board_member
Board_member
Board_member
Current Employees Featured
Dr. Mark de Boer Co-founder & CEO @ Gadeta
Co-founder & CEO
Marco Londei CEO @ Gadeta
CEO
2020-04-01
Dr. Tolleiv Trimborn COO @ Gadeta
COO
Founder
Investors List
Kite Pharma
Kite Pharma investment in Funding Round - Gadeta
Medicxi
Medicxi investment in Series A - Gadeta
Baxalta Ventures
Baxalta Ventures investment in Series A - Gadeta
Utrecht Holdings
Utrecht Holdings investment in Series A - Gadeta
Official Site Inspections
http://www.gadeta.nl
- Host name: hosted-by.greenhost.net
- IP address: 213.108.104.118
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "Gadeta"
Gadeta - Crunchbase Company Profile & Funding
Gadeta is a research and development company that develops immunotherapies for cancer. It has developed a technology platform based on combinatorial T Cell receptor exchange (CTE) to create optimized gamma delta (γδ) T-cell …See details»
Clade Therapeutics Announces the Acquisition of …
BOSTON, Oct. 02, 2023 - Clade Therapeutics (“Clade”), a biopharmaceutical company focused on discovering and delivering engineerable, off-the-shelf, scalable, and consistent stem cell-based medicines, today announced that it …See details»
Clade Therapeutics Announces the Acquisition of …
Oct 2, 2023 Gadeta is an international R&D company, focused on innovative immunotherapies for cancer. The company developed a proprietary platform to engineer novel g/d TCRs that possess broad tumor targeting ...See details»
Gadeta Company Profile 2024: Valuation, Investors, …
Gadeta General Information Description. Developer of innovative immunotherapies designed to treat cancer. The company's innovative immunotherapies are based on the discoveries regarding the role of yo T cell …See details»
Gadeta B.V. - Laboratorium.nl
Jun 15, 2019 Gadeta is a clinical stage biotechnology company developing a first-in-class cellular immunotherapy for the treatment of cancer, using a number of proprietary …See details»
Gadeta Company Profile - Office Locations, Competitors, Revenue …
Gadeta is a research and development company, discovers and develops immunotherapies for cancer. The work of the Company is based on the discoveries regarding the role of γδ T cell …See details»
Gadeta - VentureRadar
"Gadeta is a Research & Development company established in 2015 which focusses on the development of innovative immunotherapies for cancer. The work of the company is based on …See details»
Gadeta Overview | SignalHire Company Profile
Gadeta is a private company that has been in the industry for 8 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the CEO is occupied by …See details»
Clade Therapeutics acquires Gadeta - 2023-10-02 - Crunchbase
Oct 2, 2023 Clade Therapeutics acquires Gadeta on 2023-10-02 for an undisclosed amount. Search Crunchbase. Start Free Trial ... Save . Summary. Overview. Edit Overview Section. …See details»
Clade Therapeutics Announces the Acquisition of …
Oct 2, 2023 Gadeta is an international R&D company, focused on innovative immunotherapies for cancer. The company developed a proprietary platform to engineer novel g/d TCRs that possess broad tumor targeting ...See details»
Gadeta - Products, Competitors, Financials, Employees, …
Gadeta operates as a research and development company that focuses on the healthcare sector, specifically in the field of innovative immunotherapies for cancer. The company's main service …See details»
Clade Therapeutics Announces The Acquisition Of Gadeta BV
Oct 2, 2023 Clade Therapeutics (“Clade”), a biopharmaceutical company focused on discovering and delivering engineerable, off-the-shelf, scalable, and consistent stem cell-based medicines, …See details»
☑️Gadeta B.V. — Consulting Organization from the Netherlands ...
Gadeta B.V. — Consulting Organization from the Netherlands, has experience with Horizon 2020 (2014 - 2020), it`s involved in Health, Laboratory & Measurement sectorsSee details»
Gadeta - Overview, News & Similar companies | ZoomInfo.com
Gadeta contact info: Phone number: +31 850164466 Website: www.gadeta.nl What does Gadeta do? Gadeta is developing first-in-class cell therapies for the treatment of various cancers. By …See details»
Kite and Gadeta Announce Strategic Collaboration to Advance …
Jul 19, 2018 SANTA MONICA, Calif. & UTRECHT, Netherlands--(BUSINESS WIRE)--Jul. 19, 2018-- Kite, a Gilead Company (Nasdaq: GILD), and Gadeta B.V., a privately-held company …See details»
Gadeta - Contacts, Employees, Board Members, Advisors
Gadeta has 3 current employee profiles, including Co-founder & CEO Dr. Mark de Boer. Gadeta has 6 board members and advisors, including Jurgen Kuball . ContactsSee details»
Gadeta B.V. - onderzoekers.nl
Gadeta is a clinical stage biotechnology company developing a first-in-class cellular immunotherapy for the treatment of cancer, using a number of proprietary manufacturing and …See details»
Gadeta appoints Marco Londei as Chief Executive Officer
Apr 9, 2020 Strengthens management team as Gadeta receives approval to start first clinical study in multiple myeloma. 07 April 2020, Utrecht, Netherlands: Gadeta, focused on the …See details»
Gadeta announces significant progress in advancing pipeline and …
Mar 15, 2022 Giovanni Mariggi, Partner at Medicxi, and member of Gadeta's Supervisory Board, said: "We are very excited by Gadeta's progress and future plans to become a leader in the γδ …See details»
Gadeta Appoints Scientific Advisory Board and Provides Business …
Oct 20, 2022 For more information please visit: www.gadeta.nl. Disclosures. Dr Yee has an ownership interest in Gadeta and he receives compensation as a member of the company's …See details»